Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan
· Delayed Price · Currency is JPY 7,940.00
+495.00 (6.65%)
Apr 28, 2026, 3:30 PM JST
Chugai Pharmaceutical Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 417,984 | 426,602 | 540,202 | 458,674 | 222,169 | 267,753 | Upgrade
|
| Short-Term Investments | 432,111 | 553,094 | 456,143 | 280,308 | 280,938 | 204,217 | Upgrade
|
| Cash & Short-Term Investments | 850,095 | 979,696 | 996,345 | 738,982 | 503,107 | 471,970 | Upgrade
|
| Cash Growth | -10.00% | -1.67% | 34.83% | 46.88% | 6.60% | 24.65% | Upgrade
|
| Accounts Receivable | 352,747 | 442,876 | 334,256 | 318,892 | 512,538 | 355,081 | Upgrade
|
| Other Receivables | 194 | 236 | 896 | 1,456 | 1,745 | 928 | Upgrade
|
| Receivables | 352,941 | 443,112 | 335,152 | 320,348 | 514,283 | 356,009 | Upgrade
|
| Inventory | 288,289 | 276,848 | 240,067 | 273,480 | 292,206 | 208,838 | Upgrade
|
| Prepaid Expenses | - | 24,855 | 23,013 | 21,827 | 18,770 | 17,301 | Upgrade
|
| Other Current Assets | 48,116 | 16,247 | 11,466 | 11,789 | 8,171 | 9,543 | Upgrade
|
| Total Current Assets | 1,539,441 | 1,740,758 | 1,606,043 | 1,366,426 | 1,336,537 | 1,063,661 | Upgrade
|
| Property, Plant & Equipment | 481,679 | 479,481 | 441,554 | 420,701 | 386,651 | 352,107 | Upgrade
|
| Long-Term Investments | - | 105,512 | 73,073 | 61,086 | 56,185 | 44,663 | Upgrade
|
| Other Intangible Assets | 58,495 | 54,539 | 17,868 | 19,860 | 25,141 | 21,974 | Upgrade
|
| Long-Term Deferred Tax Assets | 89,422 | 88,304 | 69,835 | 64,474 | 65,244 | 56,287 | Upgrade
|
| Other Long-Term Assets | 96,064 | 1 | - | - | - | 2 | Upgrade
|
| Total Assets | 2,265,101 | 2,468,595 | 2,208,373 | 1,932,547 | 1,869,758 | 1,538,694 | Upgrade
|
| Accounts Payable | 107,524 | 127,247 | 65,353 | 112,468 | 209,835 | 152,266 | Upgrade
|
| Accrued Expenses | - | 53,591 | 49,324 | 44,629 | 37,751 | 34,421 | Upgrade
|
| Current Portion of Leases | - | 7,773 | 6,365 | 6,975 | 6,434 | 6,550 | Upgrade
|
| Current Income Taxes Payable | 51,675 | 125,721 | 142,499 | 71,573 | 121,160 | 108,293 | Upgrade
|
| Current Unearned Revenue | - | 37 | 31 | 31 | 79 | 86 | Upgrade
|
| Other Current Liabilities | 168,503 | 96,708 | 26,785 | 52,541 | 48,471 | 25,806 | Upgrade
|
| Total Current Liabilities | 327,702 | 411,077 | 290,357 | 288,217 | 423,730 | 327,422 | Upgrade
|
| Long-Term Leases | - | 17,937 | 4,532 | 6,480 | 7,675 | 9,490 | Upgrade
|
| Pension & Post-Retirement Benefits | 4,724 | 4,245 | 3,935 | 3,146 | 3,311 | 2,945 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3,434 | 4,015 | 5,076 | 5,787 | 7,086 | 7,614 | Upgrade
|
| Other Long-Term Liabilities | 21,526 | 5,589 | 2,974 | 3,337 | 3,569 | 3,206 | Upgrade
|
| Total Liabilities | 357,386 | 442,863 | 306,874 | 306,967 | 445,371 | 350,677 | Upgrade
|
| Common Stock | 73,202 | 73,202 | 73,202 | 73,202 | 73,202 | 73,202 | Upgrade
|
| Additional Paid-In Capital | 70,694 | 70,515 | 69,896 | 69,355 | 68,806 | 68,223 | Upgrade
|
| Retained Earnings | 1,763,554 | 1,890,042 | 1,746,934 | 1,488,738 | 1,293,352 | 1,054,050 | Upgrade
|
| Comprehensive Income & Other | 265 | -8,027 | 11,467 | -5,715 | -10,973 | -7,458 | Upgrade
|
| Total Common Equity | 1,907,715 | 2,025,732 | 1,901,499 | 1,625,580 | 1,424,387 | 1,188,017 | Upgrade
|
| Shareholders' Equity | 1,907,715 | 2,025,732 | 1,901,499 | 1,625,580 | 1,424,387 | 1,188,017 | Upgrade
|
| Total Liabilities & Equity | 2,265,101 | 2,468,595 | 2,208,373 | 1,932,547 | 1,869,758 | 1,538,694 | Upgrade
|
| Total Debt | - | 25,710 | 10,897 | 13,455 | 14,109 | 16,040 | Upgrade
|
| Net Cash (Debt) | 850,095 | 953,986 | 985,448 | 725,527 | 488,998 | 455,930 | Upgrade
|
| Net Cash Growth | -10.00% | -3.19% | 35.83% | 48.37% | 7.25% | 24.12% | Upgrade
|
| Net Cash Per Share | 516.55 | 579.67 | 598.82 | 440.92 | 297.20 | 277.12 | Upgrade
|
| Filing Date Shares Outstanding | 1,646 | 1,646 | 1,646 | 1,645 | 1,645 | 1,644 | Upgrade
|
| Total Common Shares Outstanding | 1,646 | 1,646 | 1,646 | 1,645 | 1,645 | 1,644 | Upgrade
|
| Working Capital | 1,211,739 | 1,329,681 | 1,315,686 | 1,078,209 | 912,807 | 736,239 | Upgrade
|
| Book Value Per Share | 1159.17 | 1230.91 | 1155.56 | 988.01 | 865.88 | 722.50 | Upgrade
|
| Tangible Book Value | 1,849,220 | 1,971,193 | 1,883,631 | 1,605,720 | 1,399,246 | 1,166,043 | Upgrade
|
| Tangible Book Value Per Share | 1123.62 | 1197.77 | 1144.70 | 975.94 | 850.59 | 709.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.